Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Mast cell stabilizer; histamine H1/2/3 antagoni...
Natriuretic, vasodilatory peptide; B1/2 agonist...
Cdc7 inhibitor.
DNA alkylator.
SERT inhibitor.
Amphibian tachykinin neuropeptide.
Organosulfur, antioxidant.
Inhibitor of glutamic acid decarboxylase (GAD)....
Endogenous peptide hormone, counteracts insulin...
Mycotoxin produced by Alternaria; photosynthesi...
ATP-sensitive K+ channel activator, α-adrenerg...
RIP1 inhibitor.
p110β PI3K inhibitor.
Salicylic acid prodrug, NSAID; weak COX-1/2 inh...
Casein kinase 2 inhibitor.
Nitrogen mustard, DNA alkylator.
Abl inhibitor.
5-Lipoxygenase inhibitor.
Aspirin analog; hemoglobin chain cross-linker.<...
Statin; HMG-CoA reductase inhibitor.